Living donor liver transplantation for biliary atresia

Shih-Ho Wang1, Chao-Long Chen, Allan Concejero

  • 1Liver Transplantation Program, Department of Surgery, Chang Gung Memorial Hospital. 123, Dapi Rd., Niaosong Township, Kaohsiung County 833, Taiwan, ROC.

Insights

Biliary atresia, a liver disease in infants, is treated with Kasai surgery or liver transplants. Living donor liver transplants offer improved survival rates for children with biliary atresia.

Area of Science:

  • Pediatric surgery
  • Hepatology
  • Organ transplantation

Background:

  • Biliary atresia is the primary cause of pediatric chronic cholestasis.
  • Kasai hepatoportoenterostomy improves survival but may require subsequent liver transplantation.
  • Living donor liver transplantation (LDLT) addresses deceased donor organ shortages.

Purpose of the Study:

  • To evaluate the outcomes of living donor liver transplantation for biliary atresia.
  • To assess the long-term survival rates following LDLT in pediatric patients.

Main Methods:

  • Retrospective analysis of 100 living donor liver transplantations for biliary atresia.
  • Data collection on recipient survival rates at 1 and 5 years post-transplant.

Main Results:

  • A total of 100 LDLTs were performed for biliary atresia.
  • Achieved 98% 1-year recipient survival.
  • Achieved 98% 5-year recipient survival.

Conclusions:

  • Living donor liver transplantation is a highly effective treatment for biliary atresia.
  • LDLT significantly improves long-term survival in pediatric patients.
  • This approach alleviates organ donor waiting times and enhances patient outcomes.